News

LAB+ Company Builder: Developing Scientific-Technological Startups

LAB+ Company Builder: Developing Scientific-Technological Startups

LAB+ Company Builder in the name for the iniciative promoted by the Institut Pasteur de Montevideo with the financial contribution and know-how of a venture capital fund led by Ficus Advisory.  The iniciative follows an internationally recognized type of structure, similar to a business accelerator, whose objective is to transform high-potential...

read more

IN THE MEDIA

Local

En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’.

Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio.

En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer.

La Diaria – What do the first four start-ups of the LAB+ seek to develop?

Telemundo  (Channel 12) – Scaffold Biotech: more efficient vaccines for animals.

En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska.

Subrayado (Channel 10) – LAB+ closed its first financing cycle.

Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+.

La Diaria – Conversations with the first four biotech start-ups funded by LAB+.

El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups.

Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups.

Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA.

Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups.

El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?

Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative.

Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies.